PRODUCTS · REGISTERED WITH MEDSAFE
XY Leap™ Omics Platform
Clinical decision support software, registered with Medsafe, New Zealand's medicines and medical devices regulator. Precision Medicine International Limited is the legal manufacturer.
How XY Leap works
What it analyzes
The XY Analytics™ engine combines an individual's toxicogenomic, nutrigenomic, exercise genomic and clinical genetic data to produce Precise, Predictive, Preventive, Participatory and Personalized (P5) recommendations.
What clinicians receive
Dosing guidance and drug-gene interaction alerts, including phenoconversion checks, across more than 1,100 therapeutics; personalized nutrition, exercise, sleep and environmental exposure insights; and reports that update as new evidence is published.
Coverage
900+ medicines with dosing guidance and phenoconversion safety checks
150 traditional medicines matched to each patient's toxicogenomic profile
75 nutraceuticals for personalized preventive and anti-inflammatory protocols
Three ways to work with us, one platform
Online application access
Licensed clinician, provider and institutional access to XY Leap
Reporting services
DNA-guided reports delivered to the point of care
Education programs
Accredited precision medicine training for doctors and pharmacists
Availability and intended use vary by country and depend on local regulatory approval. XY Leap supports, and does not replace, clinical judgment.
Education
Precision medicine training for doctors and pharmacists. Practical programs cover pharmacogenomics, toxicogenomics and how to apply DNA-guided recommendations in everyday practice.
Programs are designed for continuing medical education accreditation and are delivered online and in person with partner institutions.